26 episodes

Expert drug policy news and analysis brought to you by the leading drug policy organizations, Smart Approaches to Marijuana (SAM) and The Foundation for Drug Policy Solutions (FDPS).

The Drug Report SAM & FDPS

    • News
    • 1.0 • 1 Rating

Expert drug policy news and analysis brought to you by the leading drug policy organizations, Smart Approaches to Marijuana (SAM) and The Foundation for Drug Policy Solutions (FDPS).

    The Social Justice Illusion in Pro-Marijuana Advocacy

    The Social Justice Illusion in Pro-Marijuana Advocacy

    When Will Jones speaks, you can't help but listen. The Director of Community Engagement and Outreach at SAM brought his intense passion for marijuana policy to our conversation, enlightening us on the often overlooked complexities and challenges surrounding substance abuse in our society. His journey, deeply rooted in the experiences of his community and church, highlights the stark reality of alcohol and tobacco's impact, prompting us to consider if a third recreational substance is a burden we're prepared to shoulder. Our discussion navigates through the implications of the "Two is Enough" campaign and delves into Will's compelling reasons for opposing Initiative 71 in DC, offering a perspective that often goes unheard amidst the pro-legalization clamor.

    Our chat takes a turn into the murky waters of big tobacco, vaping, and their questionable affiliations with social justice. I bring to light the disturbing past of tobacco moguls who once denied nicotine's addictive qualities, tying it back to our eye-opening video on the Smart Approaches to Marijuana YouTube channel. Will and I dissect how these industries have co-opted social justice narratives, despite data that contradicts their claims of reducing arrests or incarceration rates for marginalized communities. As we unpack these complexities, Will invites our listeners to join the conversation on social media and online forums, challenging us to critically assess the data and ally ourselves with genuine social justice causes.
    Follow the work of SAM and FDPS below:

    https://learnaboutsam.org/
    https://gooddrugpolicy.org/
    https://thedrugreport.org/

    On X:
    https://twitter.com/learnaboutsam
    https://twitter.com/GoodDrugPolicy
    https://twitter.com/KevinSabet
    https://twitter.com/LukeNiforatos

    On Facebook: https://www.facebook.com/learnaboutsam

    • 19 min
    Milgram’s (unwitting?) Revelation & British Columbia Reverses Decriminalization

    Milgram’s (unwitting?) Revelation & British Columbia Reverses Decriminalization

    Kevin joins us to untangle the complex shifts in North American legislation. Our discussion kicks off with a deep dive into the Milgram’s stunning hearing, a perhaps unexpected twist. 

    Next we take you to the front lines of the drug decriminalization debate in British Columbia. Here, the government just announced the roll-back of its all-drug decriminalization policy amid a rising tide of public health emergencies and societal concerns. With Kevin's expert insight, we break down the political chess game influencing Canada's approach to drugs, spotlighting the importance of balancing criminal justice with public health. This is an unflinching exploration of the policies that shape our communities and the lives at stake in the throes of opioid crises and beyond.
    Follow the work of SAM and FDPS below:

    https://learnaboutsam.org/
    https://gooddrugpolicy.org/
    https://thedrugreport.org/

    On X:
    https://twitter.com/learnaboutsam
    https://twitter.com/GoodDrugPolicy
    https://twitter.com/KevinSabet
    https://twitter.com/LukeNiforatos

    On Facebook: https://www.facebook.com/learnaboutsam

    • 16 min
    Marijuana Rescheduling Latest & Hill Reactions

    Marijuana Rescheduling Latest & Hill Reactions

    We sit down with Jordan, our head of federal affairs, to dissect the implications of marijuana potentially moving to Schedule III. This seismic shift has the industry abuzz, with financial windfalls and NASDAQ listings in sight for players like Curaleaf, but it's not all green pastures. Listen closely as we explore the critical social justice issues that could be overshadowed by the allure of tax deductions and the upcoming budget hearing with DEA Administrator Ann Milgram, where the conversation will undoubtedly continue.
    Follow the work of SAM and FDPS below:

    https://learnaboutsam.org/
    https://gooddrugpolicy.org/
    https://thedrugreport.org/

    On X:
    https://twitter.com/learnaboutsam
    https://twitter.com/GoodDrugPolicy
    https://twitter.com/KevinSabet
    https://twitter.com/LukeNiforatos

    On Facebook: https://www.facebook.com/learnaboutsam

    • 11 min
    Special Episode: Kevin's Masterclass on Marijuana Rescheduling on NBC Nightly News

    Special Episode: Kevin's Masterclass on Marijuana Rescheduling on NBC Nightly News

    One of his best interviews, we're calling it the Encyclopedia Sabet-annica...
    Follow the work of SAM and FDPS below:

    https://learnaboutsam.org/
    https://gooddrugpolicy.org/
    https://thedrugreport.org/

    On X:
    https://twitter.com/learnaboutsam
    https://twitter.com/GoodDrugPolicy
    https://twitter.com/KevinSabet
    https://twitter.com/LukeNiforatos

    On Facebook: https://www.facebook.com/learnaboutsam

    • 8 min
    Marijuana Rescheduling Update

    Marijuana Rescheduling Update

    Kevin Sabet joins the conversation, bringing a laser-sharp focus to the seismic shifts that may redefine the cannabis landscape. Prepare to arm yourself with knowledge as we dissect the implications of potentially reclassifying marijuana from a Schedule 1 to Schedule 3 substance, an issue that's got stakeholders from Wall Street to Main Street perched on the edge of their seats. As rumors of an imminent decision swirl, we cut through the haze to analyze what this monumental move would mean.
    Follow the work of SAM and FDPS below:

    https://learnaboutsam.org/
    https://gooddrugpolicy.org/
    https://thedrugreport.org/

    On X:
    https://twitter.com/learnaboutsam
    https://twitter.com/GoodDrugPolicy
    https://twitter.com/KevinSabet
    https://twitter.com/LukeNiforatos

    On Facebook: https://www.facebook.com/learnaboutsam

    • 17 min
    Interview with Dr. Aaron Weiner on Addiction Industries and Prevention

    Interview with Dr. Aaron Weiner on Addiction Industries and Prevention

    Discover the unsettling truth behind vaping addiction and its intrusion into youth culture as addiction psychologist Dr. Aaron Weiner joins us to unravel the threads of behavioral health entwined with corporate profit.  Dr. Weiner's expertise shines a harsh but necessary light on the over two million kids now embroiled in nicotine use, and the shadowy influence of THC on young adults. This isn't just a health crisis; it's a maze where capitalism meets drug markets, and our exploration is set to offer both clarity and a call to action.
    Follow the work of SAM and FDPS below:

    https://learnaboutsam.org/
    https://gooddrugpolicy.org/
    https://thedrugreport.org/

    On X:
    https://twitter.com/learnaboutsam
    https://twitter.com/GoodDrugPolicy
    https://twitter.com/KevinSabet
    https://twitter.com/LukeNiforatos

    On Facebook: https://www.facebook.com/learnaboutsam

    • 16 min

Customer Reviews

1.0 out of 5
1 Rating

1 Rating

Top Podcasts In News

The News Agents
Global
The Rest Is Politics
Goalhanger Podcasts
Leading
Goalhanger Podcasts
The Daily T
The Telegraph
The Rest Is Money
Goalhanger Podcasts
Newscast
BBC News

You Might Also Like

The Journal.
The Wall Street Journal & Gimlet
All-In with Chamath, Jason, Sacks & Friedberg
All-In Podcast, LLC
Odd Lots
Bloomberg
Masters in Business
Bloomberg
WSJ What’s News
The Wall Street Journal
Psychiatry & Psychotherapy Podcast
David Puder, M.D.